NEOGENOMICS INC (NEO) Stock Price & Overview
NASDAQ:NEO • US64049M2098
Current stock price
The current stock price of NEO is 7.91 USD. Today NEO is down by -3.3%. In the past month the price increased by 1.8%. In the past year, price decreased by -22.98%.
NEO Key Statistics
- Market Cap
- 1.029B
- P/E
- 65.92
- Fwd P/E
- 49.20
- EPS (TTM)
- 0.12
- Dividend Yield
- N/A
NEO Stock Performance
NEO Stock Chart
NEO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NEO. When comparing the yearly performance of all stocks, NEO is a bad performer in the overall market: 89.94% of all stocks are doing better.
NEO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NEO. NEO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NEO Earnings
On February 17, 2026 NEO reported an EPS of 0.06 and a revenue of 190.17M. The company beat EPS expectations (53.54% surprise) and beat revenue expectations (0.13% surprise).
NEO Forecast & Estimates
18 analysts have analysed NEO and the average price target is 14.22 USD. This implies a price increase of 79.81% is expected in the next year compared to the current price of 7.91.
For the next year, analysts expect an EPS growth of 33.97% and a revenue growth 9.85% for NEO
NEO Groups
Sector & Classification
NEO Financial Highlights
Over the last trailing twelve months NEO reported a non-GAAP Earnings per Share(EPS) of 0.12. The EPS increased by 20% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.94% | ||
| ROE | -12.91% | ||
| Debt/Equity | 0.41 |
NEO Ownership
NEO Latest News, Press Relases and Analysis
NEO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.89 | 101.067B | ||
| CI | THE CIGNA GROUP | 8.95 | 73.751B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.6 | 30.256B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.26 | 22.084B | ||
| LH | LABCORP HOLDINGS INC | 14.39 | 21.774B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.526B | ||
| DVA | DAVITA INC | 10.98 | 10.356B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.71 | 9.118B | ||
| HIMS | HIMS & HERS HEALTH INC | 48.42 | 6.417B | ||
| CHE | CHEMED CORP | 14.24 | 5.595B | ||
| OPCH | OPTION CARE HEALTH INC | 15.01 | 4.48B | ||
| RDNT | RADNET INC | 86.27 | 4.38B | ||
| BLLN | BILLIONTOONE INC CL A | 172.3 | 3.858B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NEO
Company Profile
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,500 full-time employees. The company went IPO on 2012-12-10. The firm offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. The company operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Company Info
IPO: 2012-12-10
NEOGENOMICS INC
9490 Neogenomics Way
Fort Myers FLORIDA 33913 US
CEO: Douglas M. VanOort
Employees: 2500
Phone: 12397680600
NEOGENOMICS INC / NEO FAQ
What does NEO do?
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,500 full-time employees. The company went IPO on 2012-12-10. The firm offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. The company operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Can you provide the latest stock price for NEOGENOMICS INC?
The current stock price of NEO is 7.91 USD. The price decreased by -3.3% in the last trading session.
What is the dividend status of NEOGENOMICS INC?
NEO does not pay a dividend.
What is the ChartMill technical and fundamental rating of NEO stock?
NEO has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for NEOGENOMICS INC?
NEOGENOMICS INC (NEO) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the market cap for NEOGENOMICS INC?
NEOGENOMICS INC (NEO) has a market capitalization of 1.03B USD. This makes NEO a Small Cap stock.
What is the outstanding short interest for NEOGENOMICS INC?
The outstanding short interest for NEOGENOMICS INC (NEO) is 5.95% of its float.